Cisplatin-SS-MAL
Cisplatin-S-S-MAL
Product description
By combining cisplatin with an SS bond and a MAL group, Cisplatin-SS-MAL can be designed as a prodrug or a targeted drug delivery system that utilizes the cleavable disulfide bond to release cisplatin at specific locations within the body. This design allows for controlled drug release and targeted therapy, potentially reducing systemic side effects while improving the efficacy of cisplatin in cancer treatment.
Appearance | N/A |
---|---|
Molecular weight | N/A |
Purity | >90% |
Solubility | N/A |
Molecular formula | N/A |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 2 weeks |
Stability | 1 year |
Document
Related Product